drugset / Trial / NCT01575470
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if bone marrow harvest, BMMNC separation, and re-infusion in adults with acute severe TBI is safe and will improve functional outcome. 12/09/2015 Update: The study is closed to new enrollment and all follow-up visits have been completed. Data analysis is underway.
Timeline
- Start
- 2012-03
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | 6e+06 cells/kg | Intravenous |
| Subject | autologous bone marrow mononuclear cells | Cell therapy | 9e+06 cells/kg | Intravenous |
| Subject | autologous bone marrow mononuclear cells | Cell therapy | 1.2e+07 cells/kg | Intravenous |